1	5	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Adipose	_	_	NN	_	_	_	_	_
2	Tissue	_	_	NN	_	_	_	_	_
3	Inflammation	_	_	NN	_	_	_	_	_
4	during	_	_	IN	_	_	_	_	_
5	Aging	_	_	NN	_	_	_	_	_


1	Adipose	_	_	JJ	_	_	_	_	_
2	tissue	_	_	NN	_	_	_	_	_
3	plays	_	_	VBZ	_	_	_	_	_
4	an	_	_	DT	_	_	_	_	_
5	essential	_	_	JJ	_	_	_	_	_
6	role	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	age-related	_	_	JJ	_	_	_	_	_
9	metabolic	_	_	JJ	_	_	_	_	_
10	dysfunction	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	linked	_	_	VBN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	systemic	_	_	JJ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	chronic	_	_	JJ	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	low-grade	_	_	JJ	_	_	_	_	_
21	inflammation	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Aging	_	_	NN	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	associated	_	_	VBN	_	_	_	_	_
4	with	_	_	IN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	decline	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	immune	_	_	JJ	_	_	_	_	_
9	competence	_	_	NN	_	_	_	_	_
10	referred	_	_	VBN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	immunosenescence	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	which	_	_	WDT	_	_	_	_	_
16	leads	_	_	VBZ	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	chronic	_	_	JJ	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	low-grade	_	_	JJ	_	_	_	_	_
21	inflammation	_	_	NN	_	_	_	_	_
22	named	_	_	VBN	_	_	_	_	_
23	“	_	_	``	_	_	_	_	_
24	inflammaging	_	_	NN	_	_	_	_	_
25	”	_	_	''	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Adipose	_	_	NN	_	_	_	_	_
2	tissue	_	_	NN	_	_	_	_	_
3	inflammation	_	_	NN	_	_	_	_	_
4	results	_	_	VBZ	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	release	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	pro-inflammatory	_	_	JJ	_	_	_	_	_
10	cytokines	_	_	NNS	_	_	_	_	_
11	such	_	_	JJ	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	TNF-α	_	_	NNP	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	IL-1b	_	_	NNP	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	IL-6	_	_	NNP	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	monocyte	_	_	NN	_	_	_	_	_
20	chemoattractant	_	_	NN	_	_	_	_	_
21	protein	_	_	NN	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	MCP-1/CCL2	_	_	NN	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	from	_	_	IN	_	_	_	_	_
26	adipose	_	_	NN	_	_	_	_	_
27	tissue	_	_	NN	_	_	_	_	_
28	macrophages	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	these	_	_	DT	_	_	_	_	_
32	factors	_	_	NNS	_	_	_	_	_
33	are	_	_	VBP	_	_	_	_	_
34	also	_	_	RB	_	_	_	_	_
35	associated	_	_	VBN	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	presence	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	senescent	_	_	JJ	_	_	_	_	_
41	cells	_	_	NNS	_	_	_	_	_
42	(	_	_	-LRB-	_	_	_	_	_
43	p16INK4A	_	_	NN	_	_	_	_	_
44	)	_	_	-RRB-	_	_	_	_	_
45	leading	_	_	VBG	_	_	_	_	_
46	to	_	_	TO	_	_	_	_	_
47	immunosenescence	_	_	NN	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	exposure	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	macrophages	_	_	NNS	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	hormones	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	cytokines	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	chemokines	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	fatty	_	_	NN	_	_	_	_	_
14	acids	_	_	NNS	_	_	_	_	_
15	found	_	_	VBN	_	_	_	_	_
16	within	_	_	IN	_	_	_	_	_
17	dysfunctional	_	_	JJ	_	_	_	_	_
18	adipose	_	_	NN	_	_	_	_	_
19	tissue	_	_	NN	_	_	_	_	_
20	stimulates	_	_	VBZ	_	_	_	_	_
21	them	_	_	PRP	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	adopt	_	_	VB	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	pro-inflammatory	_	_	JJ	_	_	_	_	_
26	phenotype	_	_	NN	_	_	_	_	_
27	inflammation	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Age-associated	_	_	JJ	_	_	_	_	_
2	adipose	_	_	NN	_	_	_	_	_
3	tissue	_	_	NN	_	_	_	_	_
4	inflammation	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	related	_	_	VBN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	activation	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	NFκB	_	_	NN	_	_	_	_	_
13	signaling	_	_	NN	_	_	_	_	_
14	pathway	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	promotes	_	_	VBZ	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	pro-inflammatory	_	_	JJ	_	_	_	_	_
20	polarization	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	adipose	_	_	NN	_	_	_	_	_
23	tissue	_	_	NN	_	_	_	_	_
24	macrophages	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	independent	_	_	JJ	_	_	_	_	_
27	from	_	_	IN	_	_	_	_	_
28	total	_	_	JJ	_	_	_	_	_
29	adipose	_	_	NN	_	_	_	_	_
30	tissue	_	_	NN	_	_	_	_	_
31	mass	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	stimulus	_	_	NN	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	age-associated	_	_	JJ	_	_	_	_	_
5	macrophage	_	_	NN	_	_	_	_	_
6	pro-inflammatory	_	_	JJ	_	_	_	_	_
7	polarization	_	_	NN	_	_	_	_	_
8	can	_	_	MD	_	_	_	_	_
9	be	_	_	VB	_	_	_	_	_
10	associated	_	_	VBN	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	endoplasmic	_	_	JJ	_	_	_	_	_
13	reticulum	_	_	NN	_	_	_	_	_
14	stress	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	which	_	_	WDT	_	_	_	_	_
17	promotes	_	_	VBZ	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	pro-inflammatory	_	_	JJ	_	_	_	_	_
20	environment	_	_	NN	_	_	_	_	_
21	due	_	_	JJ	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	release	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	IL-6	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	MCP-1	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	TNF-α	_	_	NN	_	_	_	_	_
32	cytokines	_	_	NNS	_	_	_	_	_
33	within	_	_	IN	_	_	_	_	_
34	adipose	_	_	NN	_	_	_	_	_
35	tissue	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	decreased	_	_	VBN	_	_	_	_	_
3	vascularization	_	_	NN	_	_	_	_	_
4	promoted	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	aging	_	_	NN	_	_	_	_	_
7	promotes	_	_	VBZ	_	_	_	_	_
8	local	_	_	JJ	_	_	_	_	_
9	hypoxia	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	favors	_	_	VBZ	_	_	_	_	_
12	adipose	_	_	NN	_	_	_	_	_
13	tissue	_	_	NN	_	_	_	_	_
14	macrophage	_	_	NN	_	_	_	_	_
15	accumulation	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	macrophage	_	_	NN	_	_	_	_	_
3	infiltration	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	perpetuated	_	_	VBN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	reduction	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	mitochondrial	_	_	JJ	_	_	_	_	_
12	cytochrome	_	_	NN	_	_	_	_	_
13	c	_	_	NN	_	_	_	_	_
14	oxidase	_	_	NN	_	_	_	_	_
15	subunit	_	_	NN	_	_	_	_	_
16	5B	_	_	NN	_	_	_	_	_
17	(	_	_	-LRB-	_	_	_	_	_
18	COX5B	_	_	NN	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	component	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	complex	_	_	JJ	_	_	_	_	_
23	IV	_	_	NN	_	_	_	_	_
24	within	_	_	IN	_	_	_	_	_
25	adipocytes	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	which	_	_	WDT	_	_	_	_	_
28	inhibits	_	_	VBZ	_	_	_	_	_
29	lipolytic	_	_	JJ	_	_	_	_	_
30	signaling	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	free-fatty	_	_	JJ	_	_	_	_	_
33	acid	_	_	NN	_	_	_	_	_
34	mobilization	_	_	NN	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	increases	_	_	VBZ	_	_	_	_	_
37	intracellular	_	_	JJ	_	_	_	_	_
38	lipid	_	_	NN	_	_	_	_	_
39	storage	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Hypertrophic	_	_	JJ	_	_	_	_	_
2	expansion	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	adipocytes	_	_	NNS	_	_	_	_	_
5	promotes	_	_	VBZ	_	_	_	_	_
6	stress	_	_	NN	_	_	_	_	_
7	signals	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	thereby	_	_	RB	_	_	_	_	_
10	contributing	_	_	VBG	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	immunometabolic	_	_	JJ	_	_	_	_	_
13	dysfunction	_	_	NN	_	_	_	_	_
14	both	_	_	CC	_	_	_	_	_
15	locally	_	_	RB	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	systemically	_	_	RB	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Besides	_	_	IN	_	_	_	_	_
2	macrophages	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	dysfunctional	_	_	JJ	_	_	_	_	_
5	adipose	_	_	NN	_	_	_	_	_
6	tissue	_	_	NN	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	exacerbate	_	_	VB	_	_	_	_	_
9	immunosenescence	_	_	NN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	promoting	_	_	VBG	_	_	_	_	_
12	activation	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	differentiation	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	immune	_	_	JJ	_	_	_	_	_
17	cells	_	_	NNS	_	_	_	_	_
18	such	_	_	JJ	_	_	_	_	_
19	as	_	_	IN	_	_	_	_	_
20	B	_	_	NN	_	_	_	_	_
21	cells	_	_	NNS	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	B	_	_	NN	_	_	_	_	_
24	lymphocytes	_	_	NNS	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	nautral	_	_	JJ	_	_	_	_	_
28	killer	_	_	NN	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	NK	_	_	NN	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	lymphocytes	_	_	NNS	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	regulatory	_	_	JJ	_	_	_	_	_
35	T	_	_	NN	_	_	_	_	_
36	cells	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	neutrophils	_	_	NNS	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	eosinophils	_	_	NNS	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	mast	_	_	NN	_	_	_	_	_
43	cells	_	_	NNS	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	dendritic	_	_	JJ	_	_	_	_	_
46	cells	_	_	NNS	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Immune	_	_	NN	_	_	_	_	_
2	cell	_	_	NN	_	_	_	_	_
3	accumulation	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	AT	_	_	NN	_	_	_	_	_
6	induces	_	_	VBZ	_	_	_	_	_
7	pro-inflammatory	_	_	JJ	_	_	_	_	_
8	cytokine	_	_	NN	_	_	_	_	_
9	release	_	_	NN	_	_	_	_	_
10	leads	_	_	VBZ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	inflammasome	_	_	NN	_	_	_	_	_
13	activation	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	formation	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	crown-like	_	_	JJ	_	_	_	_	_
18	structure	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	function	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	immune	_	_	JJ	_	_	_	_	_
5	cells	_	_	NNS	_	_	_	_	_
6	have	_	_	VBP	_	_	_	_	_
7	been	_	_	VBN	_	_	_	_	_
8	investigated	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	obesity	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	however	_	_	RB	_	_	_	_	_
13	some	_	_	DT	_	_	_	_	_
14	studies	_	_	NNS	_	_	_	_	_
15	suggest	_	_	VBP	_	_	_	_	_
16	that	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	pro-inflammatory	_	_	JJ	_	_	_	_	_
19	microenvironment	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	aged	_	_	JJ	_	_	_	_	_
22	murine	_	_	NN	_	_	_	_	_
23	adipose	_	_	NN	_	_	_	_	_
24	tissue	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	characterized	_	_	VBN	_	_	_	_	_
27	by	_	_	IN	_	_	_	_	_
28	TNF-α	_	_	NNP	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	IFN-γ	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	IL-6	_	_	NNP	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	prostaglandin	_	_	NN	_	_	_	_	_
35	E2	_	_	NNP	_	_	_	_	_
36	(	_	_	-LRB-	_	_	_	_	_
37	PGE2	_	_	NN	_	_	_	_	_
38	)	_	_	-RRB-	_	_	_	_	_
39	release	_	_	NN	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	could	_	_	MD	_	_	_	_	_
42	promote	_	_	VB	_	_	_	_	_
43	NFκB	_	_	NNP	_	_	_	_	_
44	activation	_	_	NN	_	_	_	_	_
45	consequently	_	_	RB	_	_	_	_	_
46	modulate	_	_	VB	_	_	_	_	_
47	dendritic	_	_	JJ	_	_	_	_	_
48	cell	_	_	NN	_	_	_	_	_
49	function	_	_	NN	_	_	_	_	_
50	,	_	_	,	_	_	_	_	_
51	also	_	_	RB	_	_	_	_	_
52	can	_	_	MD	_	_	_	_	_
53	activate	_	_	VB	_	_	_	_	_
54	neutrophils	_	_	NNS	_	_	_	_	_
55	.	_	_	.	_	_	_	_	_


1	Controversially	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	pro-inflammatory	_	_	JJ	_	_	_	_	_
5	state	_	_	NN	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	inhibit	_	_	VB	_	_	_	_	_
8	regulatory	_	_	JJ	_	_	_	_	_
9	T	_	_	NN	_	_	_	_	_
10	cells	_	_	NNS	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	NK	_	_	NNP	_	_	_	_	_
13	lymphocytes	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	also	_	_	RB	_	_	_	_	_
17	impair	_	_	VB	_	_	_	_	_
18	anti-inflammatory	_	_	JJ	_	_	_	_	_
19	defense	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Taken	_	_	VBN	_	_	_	_	_
2	together	_	_	RB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	chronic	_	_	JJ	_	_	_	_	_
6	inflammatory	_	_	JJ	_	_	_	_	_
7	environment	_	_	NN	_	_	_	_	_
8	promoted	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	aging	_	_	NN	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	contribute	_	_	VB	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	adipose	_	_	NN	_	_	_	_	_
15	tissue	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	skeletal	_	_	JJ	_	_	_	_	_
18	muscle	_	_	NN	_	_	_	_	_
19	dysfunction	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	consequently	_	_	RB	_	_	_	_	_
22	leads	_	_	VBZ	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	feedback	_	_	NN	_	_	_	_	_
26	loop	_	_	NN	_	_	_	_	_
27	that	_	_	WDT	_	_	_	_	_
28	perpetuates	_	_	VBZ	_	_	_	_	_
29	adipose	_	_	NN	_	_	_	_	_
30	inflammation	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	redistribution	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	impairs	_	_	VBZ	_	_	_	_	_
35	progenitor	_	_	NN	_	_	_	_	_
36	cell	_	_	NN	_	_	_	_	_
37	differentiation	_	_	NN	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	leads	_	_	VBZ	_	_	_	_	_
40	to	_	_	TO	_	_	_	_	_
41	cellular	_	_	JJ	_	_	_	_	_
42	dysfunction	_	_	NN	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	death	_	_	NN	_	_	_	_	_
45	of	_	_	IN	_	_	_	_	_
46	adipocytes	_	_	NNS	_	_	_	_	_
47	and	_	_	CC	_	_	_	_	_
48	neighboring	_	_	VBG	_	_	_	_	_
49	cells	_	_	NNS	_	_	_	_	_
50	such	_	_	JJ	_	_	_	_	_
51	as	_	_	IN	_	_	_	_	_
52	skeletal	_	_	JJ	_	_	_	_	_
53	muscle	_	_	NN	_	_	_	_	_
54	cells	_	_	NNS	_	_	_	_	_
55	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	effects	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	inflammation	_	_	NN	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	skeletal	_	_	JJ	_	_	_	_	_
7	muscle	_	_	NN	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	also	_	_	RB	_	_	_	_	_
10	related	_	_	VBN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	effects	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	inflammatory	_	_	JJ	_	_	_	_	_
16	mediators	_	_	NNS	_	_	_	_	_
17	on	_	_	IN	_	_	_	_	_
18	muscle	_	_	NN	_	_	_	_	_
19	protein	_	_	NN	_	_	_	_	_
20	metabolism	_	_	NN	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	muscle	_	_	NN	_	_	_	_	_
23	protein	_	_	NN	_	_	_	_	_
24	breakdown	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	synthesis	_	_	NN	_	_	_	_	_
27	)	_	_	-RRB-	_	_	_	_	_
28	;	_	_	:	_	_	_	_	_
29	however	_	_	RB	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	way	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	which	_	_	WDT	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	inflammatory	_	_	JJ	_	_	_	_	_
36	factors	_	_	NNS	_	_	_	_	_
37	can	_	_	MD	_	_	_	_	_
38	induce	_	_	VB	_	_	_	_	_
39	muscle	_	_	NN	_	_	_	_	_
40	wasting	_	_	NN	_	_	_	_	_
41	and	_	_	CC	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	extent	_	_	NN	_	_	_	_	_
44	to	_	_	TO	_	_	_	_	_
45	which	_	_	WDT	_	_	_	_	_
46	they	_	_	PRP	_	_	_	_	_
47	do	_	_	VBP	_	_	_	_	_
48	so	_	_	RB	_	_	_	_	_
49	remains	_	_	VBZ	_	_	_	_	_
50	a	_	_	DT	_	_	_	_	_
51	largely	_	_	RB	_	_	_	_	_
52	unexplored	_	_	JJ	_	_	_	_	_
53	area	_	_	NN	_	_	_	_	_
54	of	_	_	IN	_	_	_	_	_
55	research	_	_	NN	_	_	_	_	_
56	in	_	_	IN	_	_	_	_	_
57	aging	_	_	NN	_	_	_	_	_
58	.	_	_	.	_	_	_	_	_

